Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Brent Willis is the Chairman and Chief Executive Officer of ECIG. Prior to Victory, Mr. Willis operated as the Chairman and Chief Executive Officer of a portfolio of companies including Liberty Ammunition, a leading lead-free ammunition company, Throwdown Industries, a leading mixed martial arts company, and a start-up medical device company. Mr. Willis continues to own a significant equity stake in each of these firms.
https://www.crunchbase.com/person/brent-david-willis
Edward Vranic, CFA
Edward Vranic, CFA
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
ECIG Has Become A Buyout Target For Big Tobacco After Its Failed IPO
Dec. 17, 2014 11:34 AM
Summary
ECIG has declined from a stock price of $5 to $0.11 in the matter of a few weeks over concerns of the company's convertible debt and cash position.
The company's IPO was terminated thanks to these poor market conditions, but it's valued so low that it has become a buyout target for big tobacco.
Revenue growth has been strong and the CEO's guidance suggests a very good Q4 with positive EBITDA and presumably lower cash burn.
Convertible debt holders have a very strong incentive to convert at these low prices then pursue a takeover bid that is lucrative to them and other new shareholders.
Electronic Cigarettes International Group, Ltd. (ECIG) has seen its stock price and enterprise value sharply decline since October when it set terms for its NASDAQ listing. The company planned to raise $150 million at $4.50 per share, valuing it at a $678 million market cap but poor market conditions forced the company to officially withdraw its plan on December 15. Investor concerns over its debt load and dilutive conversion provisions of its convertible notes has caused ECIG to crater from the $5 range in October to $0.11 as of market close on December 16, valuing the company at a mere $9 million in market cap and $57 million in enterprise value. While the bearish argument had merit when the company was trading in the billion dollar range, at these low prices ECIG becomes a very strong buyout target. I believe the convertible debt holders are aware of this and will take advantage of the very favorable conversion terms to participate in and influence the direction of a takeover.
Excitement over the electronic cigarette market is quite warranted. E-cigarettes work by vaporizing nicotine liquid, do not contain tobacco and there is no combustion, smoke nor odor. They have become popular as the vaping process can closely mimic the act of traditional smoking but also allows consumers to have control and choice over the product as they can mix and match component devices to save money and have a variety of flavors to choose from to make the experience more pleasant. Investor and industry craze over e-cigarettes have tempered a bit as governments worry that the process will lead to increased youth smoking and even if the trend is limited strictly to e-cigarettes, they still contain the addictive nicotine drug. E-cigarettes, in theory, are meant as an intermediary step towards smokers kicking their habit or an alternative that allows them to smoke in places where it is disallowed or shunned. Increased taxation and government restrictions on advertising and places for vaping may hurt future industry growth however the estimated sales for the U.S. vapor market alone is already $2.5 billion for 2014 with global sales expected to surpass $10 billion annually by 2017.
ECIG has been aggressive in its pursuit of this market. Through various acquisitions and organic growth of its flagship Victory brand it has managed to quickly grow from $1 million in revenue in 2013 to an estimate of more than $80 million in revenue in 2014 according to a message from the company's CEO Brent Willis to a shareholder on December 15:
This message provides important data for investors who are trying to determine if ECIG is a good speculative bet at these very low levels. The company's Q3 report showed $16 million in revenue for Q3 2014 and $31 million in revenue year-to-date. Assuming the CEO's guidance is accurate that would mean revenue for Q4 is expected to be more than $50 million. If $50 million per quarter is the starting point going into 2015, investors can speculate that the company will have revenues in excess of $200 million next year.
The company had an operating gain of $19 million in Q3 and an operating loss of $65 million year-to-date but these figures have been greatly impacted by the change in value to the warrants as the stock price fluctuates and the goodwill impairment. Excluding those two line items the operating loss is $19 million for Q3 and $42 million year-to-date. There was a one-time charge in Q3 of $5.6 million due to the aging of inventory leading to a normalized loss of $14 million for the quarter. The CEO claims an EBITDA margin in excess of 50% and an EBITDA greater than $3.2 million although the time period for those numbers is not specified. When looking at gross margin less marketing and SG&A costs, year-to-date numbers do not suggest a positive EBITDA so investors will have to carefully review Q4 numbers to see if positive EBITDA is achieved. If so, this is a very good development as the company has grown just enough to reduce its cash burn at a time when it is running low on cash.
The bearish argument on ECIG has been a strong one in 2014. Traders with a short selling focus could have pointed to the company's high cash burn rate, the fact that a major portion of its assets are goodwill and intangibles, the high short-term debt load relative to assets and to revenue and the conversion provisions on that debt that could lead to very high dilution after a tank in the stock price as valid reasons to ride a short down from $19 to less than $1. However, I believe at 11 cents the stock price has overreacted to these issues and the CEO's email points to extremely improved operating performance.
It is imperative that investors interested in ECIG understand the terms and level of its debt and the implications on the stock price. All of the debt is short-term and must be converted or refinanced within the next 12 months. The company funded its acquisitions through short term debt expecting that the IPO will allow for it to pay off its obligations as well as fund a further acquisition that has since been cancelled. The company has $48 million in debt and another $21 million in payables against only $29 million in current assets for a working capital deficit of $20 million. Page 20 of the company's Q3 filing outlines the amount, type and features associated with each security.
Conversion provisions for some of the notes are very favorable for the holder of these securities as the conversion rate can decline when the stock price declines or other dilutive activities take place. For instance, the 4% notes have the following conversion clause:
"The conversion price of the notes will be adjusted if the closing bid price for the Company's common stock on November 26, 2014 is below the conversion price, in which case the original conversion price will automatically adjust to 70% of the lowest VWAP in the 15 trading days prior to such date".
Since November 26 the stock has gone from $1 to $0.11 with an increase in volume, suggesting that some notes have been converted to shares and are being flooded into the market. Based on the definition above, we can assume that the conversion rate is at least $0.70 as the stock was trading in the $1 to $2 range in late November. In the event of a default, the holders of the 4% notes are able to convert at a price that's equal to 60% of the lowest VWAP during the 30 trading day-period immediately prior to the default event.
For the notes without explicit conversion instructions, I predict that they will be converted using a similar method based on market prices at the time they come due if a suitable refinancing option isn't successful. Dilution could be well in excess of 100%. The company's market cap of $9 million does not mean a lot at this moment, but the company's enterprise value - which includes the value of the company's debt - is still only $57 million so upside exists even with heavy dilution. I can foresee a resolution to the debt that involves it being converted into shares at 10 cents, or about 480 million shares. For the sake of simplicity and the fact that some debt may not be converted and some may have been converted at higher prices, my analysis will assume that ECIG will end up with a total float of 500 million shares with a cleaned up balance sheet that has little to no debt.
Big tobacco companies have been aggressive in the pursuit of the e-cigarette market although capturing market share has been difficult as consumers tend to go for the independent vaporizers in vape shops over the cigarette look-alikes made by the big companies that are more expensive and less diverse. Lorillard Inc. (NYSE:LO) acquired BluCigs for $135 million in 2012, which at the time had only $30 million in annual revenue so LO paid more than 4x its revenue for Blu.
ECIG has already surpassed $30 million in revenue for this year, should surpass $80 million in revenue for 2014 according to the CEO and $200 million in revenue in 2015 based on the pace set in Q4. A $135 million price tag would be just the starting point for ECIG and even at a share count of 500 million that would be $0.27 per share. A $250 million offer would be paying just 1.25x of ECIG's annual revenue and that would lead to a $0.50 per share offer. A $800 million offer would lead to a price of 4x of revenue or $1.60 per share.
The alternative to ECIG converting its debt at these bargain basement stock prices is a formal restructuring process or bankruptcy. The stock is certainly priced for that as it is only 11 cents away from zero. I believe this scenario isn't likely especially if the debt holders are given a deal that gives them cheap shares and control over the company. Wasting time in the formal bankruptcy process for a growing company in an industry that is desirable by large cigarette companies in order to maintain market share and reinvent themselves is not the best way to efficiently maximize investment profits.
I strongly believe that ECIG's plight will end with it being bought out relatively cheaply unless the CEO can find a way to maneuver the company through this working capital deficit without significantly diluting existing shareholders, including himself and other insiders, and maintain control over the company. Then the company can refuse any low-ball bids and work to gain back the market cap it had before the IPO problems cratered the stock. But even with my fairly conservative scenario where shareholders are significantly diluted and the company gets bought out for $250 million which is less than 40% of the proposed valuation of the entire company after the IPO, I still see a scenario of $0.50. That is nearly 5x upside from the current stock price versus the unlikely downside scenario of bankruptcy with shareholders being wiped out. I like the risk-to-reward profile offered by ECIG while it sits through this turmoil and I will continue to hold my position until significant price appreciation takes place.
https://seekingalpha.com/amp/instablog/1107010-edward-vranic-cfa/3561345-ecig-has-become-a-buyout-target-for-big-tobacco-after-its-failed-ipo
Brent Willis Joins Vascular Technologies, Inc. and Ultroid Technologies, Inc. as New Chief Executive Officer
July 07, 2008 09:07 AM Eastern Daylight Time
ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Vascular Technologies, Inc. and Ultroid Technologies, Inc., announce today that Brent Willis, former CCO of InBev and CEO of Cott Corporation, is appointed as Chief Executive Officer and member of the Boards of directors, effective immediately. Vascular Technologies, Inc. is the owner of the new Ultroid® medical device that has shown over 90% effectiveness in the treatment of hemorrhoids, which affect more than 75% of the world’s over-50 population. Unlike current surgical treatments, it is painless and outpatient with immediate recovery, and has likely application for the treatment of other varicose veins and spider veins.
“We are very pleased to welcome Brent to the Company and feel extremely fortunate to have someone of his caliber join our firm. He has extensive global experience and a twenty-year track record of delivering superior business performance in highly competitive and difficult environments”
"We are very pleased to welcome Brent to the Company and feel extremely fortunate to have someone of his caliber join our firm. He has extensive global experience and a twenty-year track record of delivering superior business performance in highly competitive and difficult environments," commented Michael Cao, Chairman of the Board of Directors. "The Board believes that Brent's leadership will be the lynchpin to take the Ultroid®system to the next level through expanded sales and distribution, capturing the system’s full potential in a multi-billion dollar segment.”
Prior to joining Vascular Technologies, Inc. and Ultroid Technologies, Inc., Mr. Willis was the Chief Executive Officer for Cott Corporation (COT), the President of Asia Pacific and CCO for InBev (INB.BR), where he led the transformation of the Company into the world's largest brewer. Willis has also been a President in Latin America for the Coca-Cola Company (KO) and a Vice-President at Kraft Foods (KFT), where he started his business career following distinguished service in the United States Army. He holds a Masters of Business Administration from the University of Chicago and a Bachelor of Science in Engineering from the United States Military Academy at West Point.
"I am extremely excited to join Vascular Technologies and Ultroid®, and grow the Company from near inception to real significance while doing something good at the same time. Ultroid® is a far superior treatment and far more cost effective technology for a condition that affects most of the world’s aging population. Expanding Ultroid® to meet that need is an opportunity too interesting to pass up," said Willis.
About Vascular Technologies and Ultroid Technologies
Vascular Technologies, Inc. is one of the fastest growing medical device companies in the United States. Its principal product is the breakthrough Ultroid® Medical System, a less expensive and more effective treatment than current procedures for the treatment of hemorrhoids with new applications for other varicose and spider veins. Ultroid® is a painless, non-invasive outpatient treatment with an over 90% effective rate that replaces ineffective over-the-counter creams and painful surgeries that can be accompanied by infection and prolonged recovery. The Ultroid® procedure can be performed by any physician, regardless of specialty, in their office, in approximately 10-15 minutes. Patients are able to resume their normal daily activities immediately, versus the several month recovery often associated with current laser and other surgical treatments. Ultroid® is FDA-cleared and accepted by most insurers and Medicare.
The Company's website is www.Ultroid.com. The brand names referenced in this press release are trademarks of Vascular Technologies, Inc. and Ultroid® Technologies, Inc. its affiliated companies, customers, or other third parties. The Company manages web video-enabled training clinics and markets and manufactures the Ultroid®Medical Devices.
Safe Harbor Statements
This press release may contain forward-looking statements reflecting management’s current expectations regarding future results of operations, economic performance, financial condition and achievements of the Company. The forward-looking statements are based on the assumption that operating performance will continue to exponentially grow in line with recent trends and consistent with distribution expansion. Management believes these assumptions to be reasonable but there is no assurance that they will prove to be accurate. Forward-looking statements, specifically those concerning future performance are subject to certain risks and uncertainties, and actual results may differ materially. These risks and uncertainties are detailed from time to time in the Company's filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements.
Contacts
Vascular Technologies, Inc. & Ultroid Technologies, Inc.
Media and Investor Relations
Michael Wodstrchill, 877-858-0555
ULTROID TECHONOLIES, INC.https://www.businesswire.com/news/home/20080707005515/en/Brent-Willis-Joins-Vascular-Technologies-Ultroid-Technologies
Log InSign Up
https://www.businesswire.com/news/home/20080707005515/en/Brent-Willis-Joins-Vascular-Technologies-Ultroid-Technologies
Liberty Ammo “Halo Point” 9mm, .40, .45
General Ammunition DiscussionA friend just pointed out to me that a company called Liberty Ammunition (http://www.Libertyammunition.com 11) has some pistol ammo they make which appears unique and which has their own packaging, called “Halo Point” ammo. The graphics and font that they use are a play on the same style used by the popular video game “Halo”, and they are clearly angling for the tactical guru / home-defense shooter market. The website is sort of quirky to navigate and a rep there told me they are currently redesigning, but here are some pics:
The online ordering on the website isn’t working, but if you call the number listed they will answer and you can order stuff. As of today they had 45acp in stock, but were 2 weeks out on the 9mm & .40S&W. The headstamp looks to be Lapua, at least on the first pic of 9mm. I wonder what the bullet construction consist of? I will post as soon as I have samples, or has anybody already looked into these?
The owner / CEO Brent Willis looks pretty legitimate and an online bio that I found of him said this:
Brent David Willis Net Worth
https://wallmine.com/people/63466/brent-d-willis.amp
The estimated Net Worth of Brent D Willis is at least $8.21 Million dollars as of 15 July 2019. Mr Willis owns over 25,000 units of New Age Beverages stock worth over $6,023,434 and over the last 13 years he sold NBEV stock worth over $1,825,750. In addition, he makes $362,500 as CEO & Director at New Age Beverages.Mr Willis NBEV stock SEC Form 4 insider tradingMr has made over 5 trades of the New Age Beverages stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 25,000 units of NBEV stock worth $100,000 on 15 July 2019. The largest trade he's ever made was selling 300,000 units of New Age Beverages stock on 5 April 2019 worth over $1,611,000. On average, Mr trades about 40,152 units every 35 days since 2006. As of 15 July 2019 he still owns at least 1,632,367 units of New Age Beverages stock. You can see the complete history of Mr Willis stock trades at the bottom of the page.Mr. Brent David Willis biographyBrent David Willis is the CEO & Director at New Age Beverages.What is the salary of Mr Willis?As the CEO & Director of New Age Beverages, the total compensation of Mr Willis at New Age Beverages is $362,500. There are no executives at New Age Beverages getting paid more.How old is Mr Willis?Mr Willis is 57, he's been the CEO & Director of New Age Beverages since . There are 2 older and 2 younger executives at New Age Beverages. The oldest executive at New Age Beverages Corp. is Richard C. Rife, 64, who is the Chief Legal & Admin. Officer and Corp. Sec..What's Mr Willis's mailing address?Brent's mailing address filed with the SEC is 1700 E 68th Ave, Thornton, CO 80229, USA.Insider trading at New Age BeveragesOver the last 2 years, insiders at New Age Beverages have traded over $5,509,481 worth of New Age Beverages stock and bought 1,881,821 units worth $3,112,047 . The most active insider traders include Ed Brennan, Brent D Willis, and Neil Fallon. On average, New Age Beverages executives and independent directors trade stock every 46 days with the average trade being worth of $592,182. The most recent stock trade was executed by Brent D Willis on 15 July 2019, trading 25,000 units of NBEV stock currently worth $100,000What does New Age Beverages do?New Age Beverages Corporation develops, markets, sells, and distributes healthy liquid dietary supplements and ready-to-drink (RTD) beverages. The company offers RTD tea, coffee, kombucha, energy drinks, relaxation drinks, coconut waters, functional waters, and rehydration beverages, as well as functional medical beverages. It provides its products under the Búcha Live Kombucha, XingTea, XingEnergy, Marley One Drop, Marley Mellow Mood, Marley Mate, Marley Cold Brew, Coco-Libre, PediaAde, Tahitian Noni Juice, TruAge, and Aspen Pure brands, as well as the Bio-Shield and NHanced brands. The company sells its products across 50 states in the United States; and approximately 60 countries internationally through direct-store-delivery systems, brokers and distributors, warehouses, independent product consultants, and e-commerce sites, as well as through grocery retail, natural food retail, specialty outlets, hypermarkets, club stores, pharmacies, convenience stores, gas stations, and individual independent distributors. New Age Beverages Corporation was founded in 2010 and is based in Denver, Colorado.Complete history of Mr Willis stock trades at Cott (Canada) and New Age Beverages
Insider
Trans.
Total price
Brent D Willis
Chief Executive Officer
Sale $100,000
2019-07-15
Brent D Willis
Chief Executive Officer
Sale $114,750
2019-06-17
Brent D Willis
Chief Executive Officer
Sale $1,611,000
2019-04-05
Brent D Willis
Chief Executive Officer
Buy $99,840
2018-08-24
Brent D Willis
Chief Executive Officer
Buy $100,107
2018-05-18
New Age Beverages executives and stock owners New Age Beverages executives and other stock owners filed with the SEC include:
Brent David Willis
CEO & Director
Gregory A. Gould CPA, CPA
Chief Financial Officer
Chuck Ence
VP of Fin. & Corp. Controller
Randall N. Smith
Pres of Morinda Holdings, Inc.
Richard C. Rife
Chief Legal & Admin. Officer and Corp. Sec.
Gregory A Gould
CFO
Amy L. Kuzdowicz
Reginald Kapteyn
Robert J. Evans
Brent D Willis
Chief Executive Officer
Gregory Fea
Ed Brennan
Julie Anderson
Neil Fallon
Timothy J Haas
Report TOS
Do collagen drinks really work?http://www.harpersbazaar.com/uk/beauty/skincare/a19701339/do-collagen-drinks-work/
Kombucha: Immortal Health Elixir or Homemade Poison? Kombucha is widely purported to be an incredibly healthy drink. However, some warn that it may be dangerous. Here are the details of kombucha tea. ? Read the rest here: https://www.thespruceeats.com/kombucha-health-elixer-or-poison-765066?utm_source=emailshare&utm_medium=social&utm_campaign=mobilesharebutton2 ? --- ?
Where is CBD legal? https://www.cnet.com/news/where-is-cbd-legality/
Brent David Willis Net Worth
https://wallmine.com/people/63466/brent-d-willis.amp
The estimated Net Worth of Brent D Willis is at least $8.21 Million dollars as of 15 July 2019. Mr Willis owns over 25,000 units of New Age Beverages stock worth over $6,023,434 and over the last 13 years he sold NBEV stock worth over $1,825,750. In addition, he makes $362,500 as CEO & Director at New Age Beverages.Mr Willis NBEV stock SEC Form 4 insider tradingMr has made over 5 trades of the New Age Beverages stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 25,000 units of NBEV stock worth $100,000 on 15 July 2019. The largest trade he's ever made was selling 300,000 units of New Age Beverages stock on 5 April 2019 worth over $1,611,000. On average, Mr trades about 40,152 units every 35 days since 2006. As of 15 July 2019 he still owns at least 1,632,367 units of New Age Beverages stock. You can see the complete history of Mr Willis stock trades at the bottom of the page.Mr. Brent David Willis biographyBrent David Willis is the CEO & Director at New Age Beverages.What is the salary of Mr Willis?As the CEO & Director of New Age Beverages, the total compensation of Mr Willis at New Age Beverages is $362,500. There are no executives at New Age Beverages getting paid more.How old is Mr Willis?Mr Willis is 57, he's been the CEO & Director of New Age Beverages since . There are 2 older and 2 younger executives at New Age Beverages. The oldest executive at New Age Beverages Corp. is Richard C. Rife, 64, who is the Chief Legal & Admin. Officer and Corp. Sec..What's Mr Willis's mailing address?Brent's mailing address filed with the SEC is 1700 E 68th Ave, Thornton, CO 80229, USA.Insider trading at New Age BeveragesOver the last 2 years, insiders at New Age Beverages have traded over $5,509,481 worth of New Age Beverages stock and bought 1,881,821 units worth $3,112,047 . The most active insider traders include Ed Brennan, Brent D Willis, and Neil Fallon. On average, New Age Beverages executives and independent directors trade stock every 46 days with the average trade being worth of $592,182. The most recent stock trade was executed by Brent D Willis on 15 July 2019, trading 25,000 units of NBEV stock currently worth $100,000What does New Age Beverages do?New Age Beverages Corporation develops, markets, sells, and distributes healthy liquid dietary supplements and ready-to-drink (RTD) beverages. The company offers RTD tea, coffee, kombucha, energy drinks, relaxation drinks, coconut waters, functional waters, and rehydration beverages, as well as functional medical beverages. It provides its products under the Búcha Live Kombucha, XingTea, XingEnergy, Marley One Drop, Marley Mellow Mood, Marley Mate, Marley Cold Brew, Coco-Libre, PediaAde, Tahitian Noni Juice, TruAge, and Aspen Pure brands, as well as the Bio-Shield and NHanced brands. The company sells its products across 50 states in the United States; and approximately 60 countries internationally through direct-store-delivery systems, brokers and distributors, warehouses, independent product consultants, and e-commerce sites, as well as through grocery retail, natural food retail, specialty outlets, hypermarkets, club stores, pharmacies, convenience stores, gas stations, and individual independent distributors. New Age Beverages Corporation was founded in 2010 and is based in Denver, Colorado.Complete history of Mr Willis stock trades at Cott (Canada) and New Age Beverages
Insider
Trans.
Total price
Brent D Willis
Chief Executive Officer
Sale $100,000
2019-07-15
Brent D Willis
Chief Executive Officer
Sale $114,750
2019-06-17
Brent D Willis
Chief Executive Officer
Sale $1,611,000
2019-04-05
Brent D Willis
Chief Executive Officer
Buy $99,840
2018-08-24
Brent D Willis
Chief Executive Officer
Buy $100,107
2018-05-18
New Age Beverages executives and stock owners New Age Beverages executives and other stock owners filed with the SEC include:
Brent David Willis
CEO & Director
Gregory A. Gould CPA, CPA
Chief Financial Officer
Chuck Ence
VP of Fin. & Corp. Controller
Randall N. Smith
Pres of Morinda Holdings, Inc.
Richard C. Rife
Chief Legal & Admin. Officer and Corp. Sec.
Gregory A Gould
CFO
Amy L. Kuzdowicz
Reginald Kapteyn
Robert J. Evans
Brent D Willis
Chief Executive Officer
Gregory Fea
Ed Brennan
Julie Anderson
Neil Fallon
Timothy J Haas
Report TOS
FDA warn company about illegally marketing CBD products https://www.medicalnewstoday.com/articles/325923.php
Big Highs Won't Last for New Age Beverage Stock
New CBD-infused beverages treated New Age Beverage to record highs on Friday, but reality offers a more sobering portrait.
Rick Munarriz (TMFBreakerRick)
Sep 24, 2018 at 9:00AM
It was a wild week for investors -- and more likely, speculators -- in New Age Beverages Corp. (NASDAQ:NBEV) stock. The shares nearly quadrupled last week, taking off after New Age Beverage announced that it will unveil its portfolio of cannabidiol (CBD)-infused products during next month's North American Convenience Store show.
If there's one thing we know about traders these days. it's that they love a good cannabis stock, and that's essentially how they've been treating New Age Beverages. The stock soared 287% on the week, but Friday's trading session is a cautionary tale of what can happen when coming off a big high. Shares of New Age Beverages hit an all-time high of $9.99 shortly after Friday's open, only to close sharply lower. They shed 38% of their peak intraday value by the closing bell.
Coco Libre line of coconut sparkling water in cans.
IMAGE SOURCE: NEW AGE BEVERAGES CORP.
Before you raise a glass to toast New Age...
Last week's monster rally was fun while it lasted, but investors will now want to assess what they're buying into beyond the hype. They may not like what they see.
New Age Beverages soared on the potential of CBD as a beverage additive, but there are a couple of things to consider. The efficacy, and in some states the legality, of a CBD refreshment matters, and we also need to size up the potential competition. After all, New Age Beverages doesn't hold any patents for CBD exclusivity. No one does. And this is a niche that's drumming up plenty of interest, so if it's a market worth exploring, it's going to get crowded in a hurry. Even Coca-Cola is reportedly exploring a CBD-infused drink.
Investors will want to size up what New Age Beverages is all about, and that involves a sobering look at last year's heady top-line growth. Revenue doubled in 2017, but that wasn't organic growth. New Age Beverages completed three beefy acquisitions in a span of 11 months since the summer of 2016, building out its product line to include ready-to-drink tea, coffee, kombucha, coconut water, energy, and medical beverages.
The buying spree inflated sales in a way that wasn't sustainable. Growth has stalled since the company completed its last purchase in May 2017, and New Age Beverages' revenue has declined 4% through the first half of this year.
Those who bought and sold shares of New Age Beverages last week obviously aren't concerning themselves with the long-term prospects of the company's fermented kombucha tea or its sparking coconut water. You don't trade at 6 times revenue as a profitless company in this industry. Right now, this is solely about sizing up the reception the company will receive for the products it will introduce at the annual convenience-store conference in two weeks. It's quite possible that CBD, a naturally occurring cannabinoid constituent of cannabis, can spike sales for the beverage market, but New Age Beverages has so much left to prove after rallying since sales started to materialize. Volatility will continue, but justifying the hype won't be easy.
10 stocks we like better than New Age Beverages
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.*
David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and NEW AGE BEVERAGES COM wasn't one of them! That's right -- they think these 10 stocks are even better buys
The CBD craze is getting out of hand. The FDA needs to act. https://www.washingtonpost.com/opinions/the-cbd-craze-is-getting-out-of-hand-the-fda-needs-to-act/2019/07/30/94c8024c-b211-11e9-8f6c-7828e68cb15f_story.html
CBD And Hemp May Be Legal But Discrimination Continues https://www.forbes.com/sites/irisdorbian/2019/07/30/cbd-and-hemp-may-be-legal-but-discrimination-continues/
Energy Drinks Market Grow At Impressive CAGR 7.20% By 2026 Along With Top Vendors Like Red ...
Hitech News Daily.
The global energy drinks market size was valued at $53.01 billion in 2018, and is expected to grow at a CAGR of 7.20% to reach $86.01 billion by ...
Why that CBD oil you just bought might be fake https://www.thegrowthop.com/cannabis-health/why-that-cbd-oil-you-just-bought-might-be-fake
Kombucha Is Just as Bad for You as Soda, According to Dentists https://www.vice.com/en_au/article/qv78eb/kombucha-is-just-as-bad-for-you-as-soda-according-to-dentists
The FDA Just Showed Its Hand on CBD -- Is It Time for Investors to Fold? https://finance.yahoo.com/news/fda-just-showed-hand-cbd-122100156.html
New Age Beverages May Be Risky,
But A Scam Not So Much
Jul. 28, 2019 9:16 AMNew Age Beverages Corporation (NBEV)
Summary
New Age Beverages is a risky speculative stock.
It has also come under attack from short sellers claiming dishonest practices.
Some of the points made by short sellers are worth paying attention to, but others are misleading.
New Age Beverages has a strong balance sheet, no net debt, and is nearly break-even.
Those interested in New Age Beverages should wait and see how the CBD drinks market develops, if it does at all.
Whether you’re a bull or bear on New Age Beverages (NBEV), the stock is very interesting, and could serve as a bellwether for an entirely new CBD beverage industry. Let’s not get off on the wrong foot though. New Age Beverages is not yet a CBD beverage company. Right now it is primarily a multi-level marketing Tahitian noni fruit juice company. That is certainly not why New Age is a widely followed stock. Its intent to break into the CBD-infused drinks market is the reason it gets so much attention.
According to CEO Brent Willis, the company has 25,000 shareholders. This is just a speculation, but I’d say most of these shareholders are not invested in New Age because it is a multi-level marketing company for a tropical fruit juice. They want to see CBD beverage sales.
There is significant short interest in the stock, though the levels are not extremely high. The short percentage of the float is 27%, which means that the short case is obvious enough for a quarter of its holders to buy in to it, but if they’re wrong, the potential for a short squeeze is also palpable. The company has recently come under attack from short sellers. I’d like to address the most recent one.
Grizzly NBEV Report
Grizzly Reports recently released a short report on the stock and it makes some interesting points, but in my opinion is rather flawed.
For one, regarding the CBD market, It makes claims regarding its business acquisitions that I cannot find in its filings. For example, regarding its Marley acquisition, Grizzly claims:
NBEV’s CBD related licensing deal with the Marley brand has terribly (sic) economics for NBEV. NBEV ends up paying 50% of revenue for the licensing deal, yet our research indicates that standard rates for this industry are around 25%. It will be hard to turn a profit on such unfavorable economics. However, on June 20th 2019 NBEV announced that the Marley licensing deal would be extended globally.
Searching its annual and quarterly reports since the Marley acquisition, I can find no evidence that New Age is paying 50% of revenue for the deal. (If I missed it, please comment below.) Perhaps Grizzly is calculating this cumulatively by including the purchase price offset against future expected sales, but the way it is presented in the report implies that New Age owes Marley 50% of all sales revenues in perpetuity. Regarding what New Age owes Marley going forward, this is what is written in its annual report:
…as part of the Marley transaction in 2017, we agreed to make a one-time earnout payment of $1.25 million if revenue for the Marley reporting unit is equal to or greater than $15.0 million during any trailing twelve calendar month period after the closing.
If New Age does owe Marley 50% of all sales revenues, that is not evident to me at least in its filings. This is a significant point, because much of the bullish positivity surrounding the stock has to do with its recent deals with Walmart (WMT) and 711 (OTCPK:SVNDY) for distribution of its Marley drinks. This caused a minor spike in April but shares have since fallen.
Data by YCharts
Grizzly also discusses the company’s CBD prospects, arguing that according to federal law, it is illegal to infuse food or drink with CBD for human consumption, despite the passage of the 2018 Farm Bill that legalized hemp, from which CBD can be extracted. This is technically true. What is also technically true is that selling, smoking, or otherwise ingesting cannabis is illegal according to US federal law. So, technically speaking, the federal government can legally raid any dispensary in any US state that has legalized cannabis for medical or recreational use. Will this happen? Almost certainly not. If the federal government goes after sellers of CBD-infused beverages, it will have to go after every business in every state that has legalized cannabis. That is impossible.
CBD Drink Legality
One could perhaps argue that the federal government would move to enforce its CBD regulations as a food additive because this is a separate issue to, say, THC additives in marijuana edibles, but this seems quite a long shot and would be on the face of it quite illogical for the federal government to do. The base case as I see it is that in states where cannabis is legal recreationally, there will be no federal action on CBD-infused beverages. It is still a risk though and cannot be ruled out entirely.
To illustrate this point with some color, on May 31 the FDA held a public meeting regarding CBD as a food additive. Some of the commentators put on a true spectacle, attacking the FDA with profanity for not enforcing federal marijuana laws. One of them, who was arguing for the arrest of every person selling any form of cannabis in any state that has legalized marijuana, frantically calling the laxity on that front to be “the most negligent, damaging thing I’ve ever seen a government agency do.” That is quite a hyperbolic statement, to say the least. Yet, this person actually agrees with my point above, namely that nothing will change (see page 244) on the enforcement front:
These people have been operating for years, okay? And they have ignored you. What makes you think if you come out with something now that the situation is going to be any different? The only way it's going to be different is if you enforce it. And you have not been doing that…Redeem yourselves and go after this criminal industry that's damaging our children.
Somehow I don’t see that happening.
Another participant was also frank on the issue of enforcement, submitting this more reasonable and levelheaded request of the FDA (page 354):
We respectfully ask the FDA to do one of two things: either enforce the current statutes and hold the companies responsible for manufacturing and marketing these illegal products or we urge the secretary to exercise his authority under current statute to allow hemp-derived products such as CBD to be recognized as legal dietary ingredients, provided that an NDIN is submitted and all other applicable federal laws are met.
Assuming that FDA regulations on CBD are not enforced, just as federal regulations on cannabis are not enforced in states that have legalized it, this puts New Age in a particularly interesting situation. It will not have to compete with Big Business in the CBD market, at least not initially.
Limited Initial Competition from Big Business
Back in September, Coca Cola announced that no decisions have been made regarding entering the CBD beverage market. Ben & Jerry’s ice cream has also issued a statement back in May indicating its desire to enter the market but is not moving forward yet. It’s not worth it for Big Business to violate federal law just for small change by their standards. Small companies can, since they cause less of a splash and have less to lose and more to gain.
Though it is not the first CBD beverage company to market, New Age's Marley acquisition might give it the branding it needs to appeal to early adopters in this market. As a relatively small company compared to its Big Business competitors like Coca Cola (KO), New Age looks like it is ready to “play chicken” so to speak with the FDA and the federal government generally. This is essentially what every cannabis company is doing by simply existing. New Age is not unique in this respect. It was borderline explicit on this point in its latest conference call with shareholders in that a rolling launch of its CBD products would be a regulatory test. Here is the relevant quote from the transcript:
And so it's kind of like a rolling launch. Global launch is probably not practical, but a rolling launch in terms of not only testing the demand for the market but acceptability in terms of legal regulatory world that we live in...
Chinese Discrepencies, Licensure Controversy
Back to Grizzly’s report, its main thesis actually concerns Mornida’s noni juice operations. It contends that there are discrepancies between its State Administration of Industry and Commerce ("SAIC") filings in China, and its SEC filings in the United States. True, but this can happen for many reasons unrelated to fraud or mistakes. I refer readers to this Seeking Alpha post on the subject. Second, the report claims it does not have adequate licensing for its business in China. This claim must be taken on faith, as there really is no way to verify it without being an expert in Chinese regulations. It’s a question of whether China chooses to act against New Age or not. That is not clear.
However, Grizzly is being quite selective on the licensure subject in its attack on New Age and its China multi-level marketing activities. Says Grizzly:
In early 2019, China regulators forced Natural Health Trends Corp. (NHTC) to suspend its operations in China, shortly after China Central Television ("CCTV") aired a critical report on the company. Shares fell as much as 32% on the day the story aired and are now down around 60%. Interestingly, Morinda’s primary product (90% of sales), appears to have the similar Chinese name of the product that was the subject of a China Central Television ("CCTV") scathing 2019 expose on NHTC. We are still waiting for China regulators to release its “blacklist” of untrustworthy MLM companies and participants operating in China. We believe there is a high probability that Morinda or its main operating entity in China, Tahitian Noni Beverage ("CHINA") Co., Ltd., will be on this list.
Sounds bad. Perhaps the same thing could happen to New Age? It’s certainly possible. However, what Grizzly did not say is this, from Natural Health Trends’ 2018 annual report:
We believe that neither our Hong Kong-based website nor our e-commerce platform in China require a direct selling license in China, which we currently do not hold. We have previously sought to obtain a direct selling license, and in August 2015 initiated the process for submitting a new preliminary application for a direct selling license in China.
New Age’s subsidiary Morinda does have a direct selling license. Still, to Grizzly’s credit, it does provide evidence that China has indeed “tried” (its words) to crack down on multi-level marketing companies with direct selling licenses this year, but these were because of supposed propaganda and false claims about their products. This could happen to Morinda if Chinese authorities claim it is lying about the health benefits of noni fruit juice. That’s a judgment call, and Grizzly could end up being right on this. In my view though, it is not as likely as Grizzly makes it out to be.
Healthy Finances
Assuming that its noni business is not upended suddenly, New Age looks financially healthy. I believe it acquired Morinda because it saw a good deal and wanted to secure some cash flow for investing in its CBD operations and ultimately integrate the two brands. Cash minus debt on its balance sheet is $85.45M and the company is cash flow positive at $11.44M last quarter. It was nearly break-even last quarter as well. 83% of its contractual obligations of approximately $90M are due by 2020 (see annual report page 38) and it has the cash to meet them. After that hump, it will be on easy street regarding business combination payouts and could be net positive by 2021 without the burden of those expenses.
Is New Age Beverages a speculative, risky stock? Of course it is. It could end up failing for any number of reasons. But is it in acute danger of imminent collapse and should it be shorted? With a healthy balance sheet and being near break-even, that does not seem to be the case, at least not from evidence I've seen. If you want to play this stock, the conservative way to do it is to wait and watch for three developments:
How well its Marley products sell at Walmart and 711
How well its CBD beverages sell in the markets where they are launched, including the federal government’s response or lack of it
Chinese moves against its Morinda subsidiary
If New Age comes out with a strong start to its CBD ventures and Marley takes off, then I’d say it’s a buy. If not, then either keep waiting or move on to the next trade. But short it? I don’t see a good case for that.
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Recommended for you:
Top Authors
RSS Feed
Sitemap
About Us
Feedback
Contact Us
Terms of Use
Privacy
IOS App
Android App
Facebook
Twitter
The FDA Just Showed Its Hand on CBD -- Is It Time for Investors to Fold? https://www.fool.com/investing/2019/07/29/the-fda-just-showed-its-hand-on-cbd-is-it-time-for.aspx
FDA cracks down on rogue CBD products touting unproven health claims
The FDA is trying to speed up its work to institute regulatory policies surrounding the rapidly growing CBD market while several companies sell products with unproven medical claims(Credit: Omstudio/Depositphotos)The U.S. Food and Drug Administration (FDA) is cracking down on a number of companies selling cannabidiol (CBD) products accompanied by unsubstantiated health claims. The latest target is a company called Curaleaf, which sells CBD products that it claims can treat everything from cancer and Alzheimer's, to anxiety and inflammation in dogs.Alongside the booming new recreational marijuana market in some American states has been a rapidly growing industry in products containing marijuana-derived compounds. CBD in particular has become a source of great attention in the medical research community, showing promise as a therapeutic agent that can reduce epileptic seizures in children, treat insomnia, or even potentially function as a topical antibiotic. The only legally approved therapeutic use of CBD currently is for the treatment of a rare form of epilepsy, under the brand name Epidiolex. And, while researchers are certainly exploring whether CBD is effective in treating a number of other conditions, some companies are taking advantage of this interstitial moment in time where the drug is somewhat unregulated.The latest target of the FDA's ire is Curaleaf Inc. The FDA's recently-issued warning letter to the company cites a number of instances where products were sold with grand and scientifically unsupported claims. Some of the blatantly unfounded claims cited in the FDA warning include statements from Curaleaf suggesting, "CBD has been demonstrated to have properties that counteract the growth of [and/or] spread of cancer," and, "CBD has been linked to the effective treatment of Alzheimer's disease …"As we examine potential regulatory pathways for the lawful marketing of products containing cannabis and cannabis-derived compounds like CBD, protecting and promoting public health remains our top priority," says Acting FDA Commissioner Ned Sharpless in a statement. "Selling unapproved products with unsubstantiated therapeutic claims – such as claims that CBD products can treat serious diseases and conditions – can put patients and consumers at risk by leading them to put off important medical care."Curaleaf is by no means the first company to market CBD products accompanied by unfounded medical claims. Over the past few years the FDA has sent a large number of warning letters to companies jumping on the CBD bandwagon. The fragmented legal status of marijuana across the United States has undeniably created a significant gray area allowing new companies to capitalize on the booming public attention surrounding the possible therapeutic uses of marijuana-derived compounds.The FDA is largely playing catch up at the moment, suggesting it is, "expediting work to evaluate regulatory policies related to cannabis and cannabis-derived ingredients like CBD." The FDA Principal Deputy Commissioner Amy Abernethy, hopes to report some kind of progress toward a regulatory mechanism regarding CBD later this year.”The agency has a well-established pathway for drug development and drug approvals, and we remain committed to evaluating the agency's regulatory policies related to other types of CBD products," says Abernethy. "We plan to report our progress by early this fall as we expedite our work to address the many questions about CBD. The step-wise, science-based approach we're taking protects patients and the public health, fosters innovation for safe and appropriate products, and promotes consumer confidence." Since receiving the FDA warning letter, Curaleaf has removed a number of statements from its website and social media posts. The company has also deleted its blog, and advised the FDA that several of the products questioned in the warning letter have been discontinued. “Our industry needs, wants and appreciates the work the FDA is doing to ensure there is regulation and compliance in the CBD marketplace," says Joseph Lusardi, CEO of Curaleaf, in a recent statement. "We care deeply about our customers and making a difference in our industry. Curaleaf is committed to being an ethical and responsible company and working with the FDA to be a leader in our industry, setting the standards and guidelines to best service our customers and the communities we serve."
Source: FDA
https://newatlas.com/cbd-fda-warning-unproven-health-science-claims/60789/
Brent David Willis Net Worth
https://wallmine.com/people/63466/brent-d-willis.amp
The estimated Net Worth of Brent D Willis is at least $8.21 Million dollars as of 15 July 2019. Mr Willis owns over 25,000 units of New Age Beverages stock worth over $6,023,434 and over the last 13 years he sold NBEV stock worth over $1,825,750. In addition, he makes $362,500 as CEO & Director at New Age Beverages.Mr Willis NBEV stock SEC Form 4 insider tradingMr has made over 5 trades of the New Age Beverages stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 25,000 units of NBEV stock worth $100,000 on 15 July 2019. The largest trade he's ever made was selling 300,000 units of New Age Beverages stock on 5 April 2019 worth over $1,611,000. On average, Mr trades about 40,152 units every 35 days since 2006. As of 15 July 2019 he still owns at least 1,632,367 units of New Age Beverages stock. You can see the complete history of Mr Willis stock trades at the bottom of the page.Mr. Brent David Willis biographyBrent David Willis is the CEO & Director at New Age Beverages.What is the salary of Mr Willis?As the CEO & Director of New Age Beverages, the total compensation of Mr Willis at New Age Beverages is $362,500. There are no executives at New Age Beverages getting paid more.How old is Mr Willis?Mr Willis is 57, he's been the CEO & Director of New Age Beverages since . There are 2 older and 2 younger executives at New Age Beverages. The oldest executive at New Age Beverages Corp. is Richard C. Rife, 64, who is the Chief Legal & Admin. Officer and Corp. Sec..What's Mr Willis's mailing address?Brent's mailing address filed with the SEC is 1700 E 68th Ave, Thornton, CO 80229, USA.Insider trading at New Age BeveragesOver the last 2 years, insiders at New Age Beverages have traded over $5,509,481 worth of New Age Beverages stock and bought 1,881,821 units worth $3,112,047 . The most active insider traders include Ed Brennan, Brent D Willis, and Neil Fallon. On average, New Age Beverages executives and independent directors trade stock every 46 days with the average trade being worth of $592,182. The most recent stock trade was executed by Brent D Willis on 15 July 2019, trading 25,000 units of NBEV stock currently worth $100,000What does New Age Beverages do?New Age Beverages Corporation develops, markets, sells, and distributes healthy liquid dietary supplements and ready-to-drink (RTD) beverages. The company offers RTD tea, coffee, kombucha, energy drinks, relaxation drinks, coconut waters, functional waters, and rehydration beverages, as well as functional medical beverages. It provides its products under the Búcha Live Kombucha, XingTea, XingEnergy, Marley One Drop, Marley Mellow Mood, Marley Mate, Marley Cold Brew, Coco-Libre, PediaAde, Tahitian Noni Juice, TruAge, and Aspen Pure brands, as well as the Bio-Shield and NHanced brands. The company sells its products across 50 states in the United States; and approximately 60 countries internationally through direct-store-delivery systems, brokers and distributors, warehouses, independent product consultants, and e-commerce sites, as well as through grocery retail, natural food retail, specialty outlets, hypermarkets, club stores, pharmacies, convenience stores, gas stations, and individual independent distributors. New Age Beverages Corporation was founded in 2010 and is based in Denver, Colorado.Complete history of Mr Willis stock trades at Cott (Canada) and New Age Beverages
Insider
Trans.
Total price
Brent D Willis
Chief Executive Officer
Sale $100,000
2019-07-15
Brent D Willis
Chief Executive Officer
Sale $114,750
2019-06-17
Brent D Willis
Chief Executive Officer
Sale $1,611,000
2019-04-05
Brent D Willis
Chief Executive Officer
Buy $99,840
2018-08-24
Brent D Willis
Chief Executive Officer
Buy $100,107
2018-05-18
New Age Beverages executives and stock owners New Age Beverages executives and other stock owners filed with the SEC include:
Brent David Willis
CEO & Director
Gregory A. Gould CPA, CPA
Chief Financial Officer
Chuck Ence
VP of Fin. & Corp. Controller
Randall N. Smith
Pres of Morinda Holdings, Inc.
Richard C. Rife
Chief Legal & Admin. Officer and Corp. Sec.
Gregory A Gould
CFO
Amy L. Kuzdowicz
Reginald Kapteyn
Robert J. Evans
Brent D Willis
Chief Executive Officer
Gregory Fea
Ed Brennan
Julie Anderson
Neil Fallon
Timothy J Haas
CEO LEAVES BEVERAGE MAKER COTT
Cott Corp. (TSX: BCB) shares jumped more than 12 per cent Monday after the company parted ways with Brent Willis, the chief executive officer brought in to help rescue the soda pop maker.Stock in the biggest maker of store-brand soft drinks gained 23 cents to $2.08 on the Toronto Stock Exchange. Cott shares had hit a low of $1.74 last week, down from a 52-week high of $19.70.Cott, which lost $76.8 million (U.S.) in the fourth quarter, said director David Gibbons has been named interim CEO effective immediately.Willis had taken over as chief executive in late May 2006, presiding over a series of production glitches amid rising costs for plastic and other materials, and ebbing demand for fizzy soft drinks.He had previously worked at InBev NV, the world's largest brewer, and succeeded John Sheppard, who also lasted only about two years as Cott's CEO.Willis was spectacularly unsuccessful in arresting the decline," said Peter Holden, an analyst with Veritas Investment Research.”Margins have been steadily falling, volumes have been dropping." Cott has struggled to maintain its private-label beverage dominance in the face of changing tastes and intensifying big-brand competition. Last month the company received notice it was losing some of its shelf space and merchandising support at Wal-Mart in the United States, its biggest customer.To help counter the flattening popularity of carbonated drinks, Cott has shifted its focus to bottled water and energy drinks.Gibbons said that the board has asked him to remain committed to the company's strategy.This "calls for continued focus on our core retailer-branded CSD (carbonated soft drink) business while pursuing new products and channels that reflect the changing consumer landscape," stated Gibbons, previously CEO of retailer-brand over-the-counter drug maker Perrigo Co.Cott chairman Frank Weise lauded Gibbons' knowledge of the private-label business and customer relationships, and added: "The internal challenges that we have experienced in no way negate our strategy, our industry position, or our potential for growth and success."However, the long-term outlook is "very gloomy," said analyst. I don’t think the next management will have any more luck that the previous management, or the management before that," he said."It's more than just the past two years. The company has been in decline for three or four years."According to Cott's latest disclosure, almost a year old, Willis, 48, earned total compensation of $3.6 million (U.S.) for his seven months of service in 2006, and his employment contract guaranteed a termination or resignation payment of two year's salary and bonus, plus vesting of share awards.https://www.thestar.com/business/2008/03/24/ceo_leaves_beverage_maker_cott.html
Cannabis in China has been illegal since 1985. However, hemp grows in China, and historically has been used for fiber, as well as for some ritual purposes within Taoism.
History in the 19th century, the majority-Muslim Xinjang region was a major producer and exporter of hashish, with Yarkand being a major center.[1] Tens of thousands of kilograms annually were exported to British India, legally and under tariff, until 1934 when Chinese authorities cut off the legal trade, though smuggling continued for some years after.[2]Má a Chinese word for cannabis Ma or Má (Mandarin pronunciation: [ma?]), a Chinese word for cannabis, is represented by the Han character 3][4][5] The term ma, used to describe medical marijuana by 2700 BCE, is the oldest recorded name for the hemp plant.[6]The word ma has been used to describe the cannabis plant since before the invention of writing five-thousand years ago. Ma might share a common root with the Proto-Semiticword mrr, meaning "bitter." Evidence of the earliest human cultivation of ma was found off the coast of mainland China, on the island of Taiwan.[7][8][9] Ancient Chinese prose and poems, including poetry in the Shi jing (Book of Odes), mention the word ma many times. An early song refers to young women weaving ma into clothing.[3][10][9]The word ma is often paired with the Chinese word for "big" or "great" to form the compound word dama or (dàmá). Dama is sometimes used to describe industrial hemp, as there is a negative connotation meaning "numbness" associated with the word ma by itself.[11][12] Historical Chinese medical texts (c. 200 CE) through contemporary twentieth century Chinese medical literature discuss individual terms for ma, including mafen, mahua, and mabo,referring to specific parts of the male and female flowers of a cannabis plant with differing cannabinoid ratios.[13]Legal status In 1985, the People's Republic of Chinajoined the Convention on Psychotropic Substances and identified marijuana as a dangerous narcotic drug, and illegal to possess or use it. The penalty for marijuana possession in China is disputed from various sources, but according to the Law on Public Security Administration Punishments, marijuana smokers shall be detained for 10 to 15 days and fined a maximum of 2,000 yuan.[14]https://en.m.wikipedia.org/wiki/Cannabis_in_China
————————————————————-
New Age Launches CBD In Hong Kong, China
ACCESSWIRE
ACCESSWIREJune 18, 2019, 12:10 PM UTC
DENVER, CO / ACCESSWIRE / June 18, 2019 / NEW AGE BEVERAGES CORPORATION (NBEV), the Colorado and Utah-based organic and natural products company intending to become the world's leading healthy products company, today announced the launch of their CBD portfolio into Hong Kong, its first major international expansion.
KEY HIGHLIGHTS:
New Age launches its first international country with the launch of the 'NHANCED CBD into Hong Kong, China. Plans to launch in an additional 58 countries in Q3 and Q4 as part of its drive to lead in CBD products worldwide.CBD portfolio launching under the Health Sciences Division umbrella delivering the R&D, medical insight and science to provide consumers the most trusted products available.New Age CBD launch through all of its channels - direct-to consumer, traditional retail, e-commerce, medical and specialty channels.Under the umbrella of its Health Sciences Division wholly-owned subsidiary, New Age is shipping its premium portfolio of CBD oils, creams, and lotions to Hong Kong beginning June 18th 2019, with activation across its entire global direct-to-consumer channel under its 'NHANCED CBD brand name. The launch will initially cover the areas of Hong Kong Island, Kowloon, and the New Territories and will feature three distinct products, CBD Body Cream at 150mg CBD strength, CBD Roll-on Gel at 200mg CBD strength, and CBD Oil at 500mg CBD strength. The products will be sold immediately through the direct-to-consumer product consultants, as well as through a new dedicated e-commerce website www.NHANCEDCBD.com.
Jerry Haase, M.D., Chief Medical and Scientific Officer for the New Age Health Sciences Division commented, "The Health Sciences Division at New Age is so proud to bring all these superior clinical products to consumers. We have years of study in cannabinoids, and one of the most extensive arrays of intellectual property in the beverage industry at New Age. Our launch of CBD leverages that depth of expertise to provide a highly efficacious CBD portfolio to consumers."
New Age's CBD product line features full-spectrum CBD, which means the CBD has been distilled with the lipids and fillers removed, while still maintaining a full spectrum of CBD and other cannabinoids. This diversity in phytonutrient makeup creates a cohesion and synergy among the cannabinoids. The hemp source, delicate CBD extraction, processing techniques, and the nature of the CBD itself all differentiate the New Age CBD product line from competitors. 'NHANCED CBD and the Health Sciences CBD products are sourced from hemp grown outdoors in farms located in the Pacific Northwest region of the United States.Shon Whitney, Senior Vice President of Sales and Marketing at Morinda added, "The launch of CBD in Hong Kong and China is another step in our drive for worldwide leadership in the emerging CBD sector. In addition to this launch, we have already finalized formulas and are moving to production of CBD-infused beverages and dietary supplements, which we are launching in initial markets this year and will continue to roll-out globally as the regulatory landscape allows.About New Age Beverages Corporation (NASDAQ: NBEV)
New Age Beverages Corporation is a Colorado and Utah-based healthy products company dedicated to inspiring and educating consumers to "live healthy". The Company is the only omni-channel company with access to traditional retail, e-commerce, direct-to-consumer, and medical channels across 60 countries around the world. New Age is also the only one-stop-shop of healthy products and includes the brands Tahitian Noni, TeMana, Búcha Live Kombucha, XingTea, Coco-Libre, Marley, 'NHANCED and others. New Age competes in the growth segments of the >$1 trillion-dollar non-alcoholic beverage industry and has become one of the 40 largest non-alcoholic beverage companies, one of the largest healthy beverage companies, and the fastest growing in the world over the past three years. The Company's brands are sold across all 50 states within the US and in more than 60 countries internationally across all channels via a hybrid of direct-to-consumer and traditional distribution and route-to-market systems.New Age has exclusively partnered with the world's 5th largest water charity, WATERisLIFE, to end the world water crisis with the most innovative technologies available. Donate at WATERisLIFE.com to help us #EnditToday.The Company operates the websites www.newagebev.com, www.newagebev.us, www.morinda.com, www.mybucha.com, www.xingtea.com, www.drinkmarley.com,www.nhancedcbd.com, and www.cocolibre.com.
Safe Harbor Disclosure
This press release contains forward-looking statements that are made pursuant to the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are any statement reflecting management's current expectations regarding future results of operations, economic performance, financial condition and achievements of the Company including statements regarding New Age Beverage's expectation to see continued growth. The forward-looking statements are based on the assumption that operating performance and results will continue in line with historical results. Management believes these assumptions to be reasonable but there is no assurance that they will prove to be accurate. Forward-looking statements, specifically those concerning future performance are subject to certain risks and uncertainties, and actual results may differ materially. New Age Beverages competes in a rapidly growing and transforming industry, and other factors disclosed in the Company's filings with the Securities and Exchange Commission might affect the Company's operations. Unless required by applicable law, NBEV undertakes no obligation to update or revise any forward-looking statements.For investor inquiries about New Age Beverages Corporation please contact: Media:Desiree Rosa
MULTIPLYTel: 202-292-4566
NewAgeBev@wearemultip.ly
Investor Relations Counsel:
Cody Slach, Gateway
Tel 949-574-3860
NBEV@GatewayIR.com
New Age Beverages Corporation:
Greg Gould
Chief Financial and Administrative Officer
Tel 303-289-8655
GGould@NewAgeBev.com
SOURCE: New Age Beverages Corporation
View source version on accesswire.com:
https://www.accesswire.com/549085/New-Age-Launches-CBD-In-Hong-Kong-
CALCOL INC. (@kulongenergybev)
7/25/19, 1:10 PM
pic.twitter.com/V1uu9Xxo5f
An Old Bull on New Age Beverages Is a New Bear
Rick Munarriz, The Motley Fool
Rick Munarriz, The Motley Fool
Motley FoolJuly 23, 2019, 1:30 PM UTC
One of the more notable bulls in the New Age Beverages (NASDAQ: NBEV) camp is getting cold feet. Northland analyst Mike Grondahl downgraded the distributor of functional beverages on Monday, lowering his rating on the stock from outperform to market perform.
Grondahl feels that his initial estimates for New Age Beverages following its acquisition of the much larger Morinda Holdings late last year were overambitious. He's lowering his 2019 revenue forecast from $320 million to $283 million, and it's not the only thing getting slashed. His price target is dropping from $8 to a Street low of $5. The stock responded by taking a 9% hit on Monday following the downgrade, hitting its lowest levels since late November of last year.
Good to the last dropNew Age Beverages was starting to lost traction last year. It's line of healthy and functional beverages including ready-to-drink coffee and tea, energy drinks, and kombucha was losing steam. New Age Beverages would go on to post back-to-back quarters of double-digit declines in revenue in the second and third quarter of last year.New Age Beverages had a plan to spice things up. It would go on to introduce a line of CBD-infused drinks at an industry trade show in the fall, and in December it announced the cash-and-stock deal for Morinda -- a move that would dramatically boost sales while also opening international distribution outlets for its existing products. The buzz ahead of its official cannabidiol beverage launch made the stock popular with speculators given the shortage of marijuana-related investments, and the Morinda purchase made sense on paper. The stock would go on to soar 140% in 2018, only to resume its sinking ways in recent months.Northland's Grondahl had boosted his price target on the shares from $6 to $8 in early January, encouraged by the passing of the farm bill that would theoretically make it easier for New Age Beverages to start stocking its CBD-juiced products across the country. He was also excited about Morinda's reach, giving New Age Beverages 160,000 new direct-to-consumer distribution points to market its other beverages. Reality doesn't appear to be living up to hype, and now Grondahl is staying on the sidelines with his neutral rating on the stock.
New Age Beverages has always been a risky investment, and now it's starting to seem as if Morinda was selling itself cheap for a reason. Investors may as well wait out the next few quarters to see if the thesis improves, especially now that the stock is at its lowest level of 2019.
10 stocks we like better than New Age Beverages Corporation
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.*
David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and New Age Beverages Corporation wasn't one of them! That's right -- they think these 10 stocks are even better buys.
https://finance.yahoo.com/news/old-bull-age-beverages-bear-133000493.html
Cannabis in China has been illegal since 1985. However, hemp grows in China, and historically has been used for fiber, as well as for some ritual purposes within Taoism.
History in the 19th century, the majority-Muslim Xinjang region was a major producer and exporter of hashish, with Yarkand being a major center.[1] Tens of thousands of kilograms annually were exported to British India, legally and under tariff, until 1934 when Chinese authorities cut off the legal trade, though smuggling continued for some years after.[2]Má a Chinese word for cannabis Ma or Má (Mandarin pronunciation: [ma?]), a Chinese word for cannabis, is represented by the Han character 3][4][5] The term ma, used to describe medical marijuana by 2700 BCE, is the oldest recorded name for the hemp plant.[6]The word ma has been used to describe the cannabis plant since before the invention of writing five-thousand years ago. Ma might share a common root with the Proto-Semiticword mrr, meaning "bitter." Evidence of the earliest human cultivation of ma was found off the coast of mainland China, on the island of Taiwan.[7][8][9] Ancient Chinese prose and poems, including poetry in the Shi jing (Book of Odes), mention the word ma many times. An early song refers to young women weaving ma into clothing.[3][10][9]The word ma is often paired with the Chinese word for "big" or "great" to form the compound word dama or (dàmá). Dama is sometimes used to describe industrial hemp, as there is a negative connotation meaning "numbness" associated with the word ma by itself.[11][12] Historical Chinese medical texts (c. 200 CE) through contemporary twentieth century Chinese medical literature discuss individual terms for ma, including mafen, mahua, and mabo,referring to specific parts of the male and female flowers of a cannabis plant with differing cannabinoid ratios.[13]Legal status In 1985, the People's Republic of Chinajoined the Convention on Psychotropic Substances and identified marijuana as a dangerous narcotic drug, and illegal to possess or use it. The penalty for marijuana possession in China is disputed from various sources, but according to the Law on Public Security Administration Punishments, marijuana smokers shall be detained for 10 to 15 days and fined a maximum of 2,000 yuan.[14]https://en.m.wikipedia.org/wiki/Cannabis_in_China
————————————————————-
New Age Launches CBD In Hong Kong, China
ACCESSWIRE
ACCESSWIREJune 18, 2019, 12:10 PM UTC
DENVER, CO / ACCESSWIRE / June 18, 2019 / NEW AGE BEVERAGES CORPORATION (NBEV), the Colorado and Utah-based organic and natural products company intending to become the world's leading healthy products company, today announced the launch of their CBD portfolio into Hong Kong, its first major international expansion.
KEY HIGHLIGHTS:
New Age launches its first international country with the launch of the 'NHANCED CBD into Hong Kong, China. Plans to launch in an additional 58 countries in Q3 and Q4 as part of its drive to lead in CBD products worldwide.CBD portfolio launching under the Health Sciences Division umbrella delivering the R&D, medical insight and science to provide consumers the most trusted products available.New Age CBD launch through all of its channels - direct-to consumer, traditional retail, e-commerce, medical and specialty channels.Under the umbrella of its Health Sciences Division wholly-owned subsidiary, New Age is shipping its premium portfolio of CBD oils, creams, and lotions to Hong Kong beginning June 18th 2019, with activation across its entire global direct-to-consumer channel under its 'NHANCED CBD brand name. The launch will initially cover the areas of Hong Kong Island, Kowloon, and the New Territories and will feature three distinct products, CBD Body Cream at 150mg CBD strength, CBD Roll-on Gel at 200mg CBD strength, and CBD Oil at 500mg CBD strength. The products will be sold immediately through the direct-to-consumer product consultants, as well as through a new dedicated e-commerce website www.NHANCEDCBD.com.
Jerry Haase, M.D., Chief Medical and Scientific Officer for the New Age Health Sciences Division commented, "The Health Sciences Division at New Age is so proud to bring all these superior clinical products to consumers. We have years of study in cannabinoids, and one of the most extensive arrays of intellectual property in the beverage industry at New Age. Our launch of CBD leverages that depth of expertise to provide a highly efficacious CBD portfolio to consumers."
New Age's CBD product line features full-spectrum CBD, which means the CBD has been distilled with the lipids and fillers removed, while still maintaining a full spectrum of CBD and other cannabinoids. This diversity in phytonutrient makeup creates a cohesion and synergy among the cannabinoids. The hemp source, delicate CBD extraction, processing techniques, and the nature of the CBD itself all differentiate the New Age CBD product line from competitors. 'NHANCED CBD and the Health Sciences CBD products are sourced from hemp grown outdoors in farms located in the Pacific Northwest region of the United States.Shon Whitney, Senior Vice President of Sales and Marketing at Morinda added, "The launch of CBD in Hong Kong and China is another step in our drive for worldwide leadership in the emerging CBD sector. In addition to this launch, we have already finalized formulas and are moving to production of CBD-infused beverages and dietary supplements, which we are launching in initial markets this year and will continue to roll-out globally as the regulatory landscape allows.About New Age Beverages Corporation (NASDAQ: NBEV)
New Age Beverages Corporation is a Colorado and Utah-based healthy products company dedicated to inspiring and educating consumers to "live healthy". The Company is the only omni-channel company with access to traditional retail, e-commerce, direct-to-consumer, and medical channels across 60 countries around the world. New Age is also the only one-stop-shop of healthy products and includes the brands Tahitian Noni, TeMana, Búcha Live Kombucha, XingTea, Coco-Libre, Marley, 'NHANCED and others. New Age competes in the growth segments of the >$1 trillion-dollar non-alcoholic beverage industry and has become one of the 40 largest non-alcoholic beverage companies, one of the largest healthy beverage companies, and the fastest growing in the world over the past three years. The Company's brands are sold across all 50 states within the US and in more than 60 countries internationally across all channels via a hybrid of direct-to-consumer and traditional distribution and route-to-market systems.New Age has exclusively partnered with the world's 5th largest water charity, WATERisLIFE, to end the world water crisis with the most innovative technologies available. Donate at WATERisLIFE.com to help us #EnditToday.The Company operates the websites www.newagebev.com, www.newagebev.us, www.morinda.com, www.mybucha.com, www.xingtea.com, www.drinkmarley.com,www.nhancedcbd.com, and www.cocolibre.com.
Safe Harbor Disclosure
This press release contains forward-looking statements that are made pursuant to the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are any statement reflecting management's current expectations regarding future results of operations, economic performance, financial condition and achievements of the Company including statements regarding New Age Beverage's expectation to see continued growth. The forward-looking statements are based on the assumption that operating performance and results will continue in line with historical results. Management believes these assumptions to be reasonable but there is no assurance that they will prove to be accurate. Forward-looking statements, specifically those concerning future performance are subject to certain risks and uncertainties, and actual results may differ materially. New Age Beverages competes in a rapidly growing and transforming industry, and other factors disclosed in the Company's filings with the Securities and Exchange Commission might affect the Company's operations. Unless required by applicable law, NBEV undertakes no obligation to update or revise any forward-looking statements.For investor inquiries about New Age Beverages Corporation please contact: Media:Desiree Rosa
MULTIPLYTel: 202-292-4566
NewAgeBev@wearemultip.ly
Investor Relations Counsel:
Cody Slach, Gateway
Tel 949-574-3860
NBEV@GatewayIR.com
New Age Beverages Corporation:
Greg Gould
Chief Financial and Administrative Officer
Tel 303-289-8655
GGould@NewAgeBev.com
SOURCE: New Age Beverages Corporation
View source version on accesswire.com:
https://www.accesswire.com/549085/New-Age-Launches-CBD-In-Hong-Kong-
CEO leaves beverage maker Cott
Mon., March 24, 2008
Cott Corp. (TSX: BCB) shares jumped more than 12 per cent Monday after the company parted ways with Brent Willis, the chief executive officer brought in to help rescue the soda pop maker.
Stock in the biggest maker of store-brand soft drinks gained 23 cents to $2.08 on the Toronto Stock Exchange. Cott shares had hit a low of $1.74 last week, down from a 52-week high of $19.70.Cott, which lost $76.8 million (U.S.) in the fourth quarter, said director David Gibbons has been named interim CEO effective immediately.
Willis had taken over as chief executive in late May 2006, presiding over a series of production glitches amid rising costs for plastic and other materials, and ebbing demand for fizzy soft drinks.
He had previously worked at InBev NV, the world's largest brewer, and succeeded John Sheppard, who also lasted only about two years as Cott's CEO.”Willis was spectacularly unsuccessful in arresting the decline," said Peter Holden, an analyst with Veritas Investment Research.
“Margins have been steadily falling, volumes have been dropping."
Cott has struggled to maintain its private-label beverage dominance in the face of changing tastes and intensifying big-brand competition. Last month the company received notice it was losing some of its shelf space and merchandising support at Wal-Mart in the United States, its biggest customer.To help counter the flattening popularity of carbonated drinks, Cott has shifted its focus to bottled water and energy drinks.Gibbons said that the board has asked him to remain committed to the company's strategy.This "calls for continued focus on our core retailer-branded CSD (carbonated soft drink) business while pursuing new products and channels that reflect the changing consumer landscape," stated Gibbons, previously CEO of retailer-brand over-the-counter drug maker Perrigo Co.Cott chairman Frank Weise lauded Gibbons' knowledge of the private-label business and customer relationships, and added: "The internal challenges that we have experienced in no way negate our strategy, our industry position, or our potential for growth and success."
New Age Beverages Corporation [NBEV] Holding Strong: What’s pushing it?
By Kevin Freeman
New Age Beverages Corporation [NASDAQ: NBEV] shares went lower by -7.53% from its previous closing of $4.05, now trading at the price of $3.74, also adding -0.31 points. Is NBEV stock a buy or should you stay away?The stock had a rather active trading session with the latest closing, by far recording 3.08 million contracts. Compared to the average trading volume of NBEV shares, the company saw a far better performance. Moreover, the stock has a float and a -6.06% run over in the last seven days. NBEV share price has been hovering between $9.99 and $1.30 lately, and is definitely worthy of attention.
New Age Beverages Corporation [NASDAQ:NBEV]: Analyst Rating and Earnings Pro stock market traders often keep their attention pointed at what top market analysts have to say regarding a potential equity investment. For New Age Beverages Corporation [NBEV] currently, the latest-available mean analyst rating is for the fiscal quarter that will end in December. On average, stock market experts give NBEV an Buy rating. Its stock price has been found in the range of 1.30 to 9.99. This is compared to its latest closing price of $4.05.Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for New Age Beverages Corporation [NBEV] is sitting at 1.50. This is compared to 1 month ago, when its average rating was 1.80.
For the quarter ending in Mar-19 New Age Beverages Corporation [NBEV] generated $0.06 billion in sales. That’s 5.77% lower than the average estimate of $0.06 billion as provided by Wall Street analysts. The three indicators above suggest that on the whole, this stock is not presenting an attractive investment option, as there are too many red flags that don’t point to a high-value ROI.Keep your eyes peeled for this company’s upcoming financial results publication, which is slated for Tue 13 Aug (In 22 Days).Fundamental Analysis of New Age Beverages Corporation [NBEV]
Now let’s turn to look at profitability: with a current Operating Margin for New Age Beverages Corporation [NBEV] sitting at -30.84 and its Gross Margin at +13.39, this company’s Net Margin is now -11.20%. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.This company’s Return on Total Capital is -13.52, and its Return on Invested Capital has reached -6.60%. Its Return on Equity is -11.71, and its Return on Assets is -6.84. These metrics suggest that this New Age Beverages Corporation does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.Turning to investigate this organization’s capital structure, New Age Beverages Corporation [NBEV] has generated a Total Debt to Total Equity ratio of 15.00. Similarly, its Total Debt to Total Capital is 13.04, while its Total Debt to Total Assets stands at 8.08. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 9.71, and its Long-Term Debt to Total Capital is 8.45. This company has a healthy balance between its debt and its current holdings, suggesting it is a reliable investment due to its ability to leverage debt in an efficient way.What about valuation? This company’s Enterprise Value to EBITDA is -21.09. The Enterprise Value to Sales for this firm is now 2.94, and its Total Debt to Enterprise Value stands at 0.10. New Age Beverages Corporation [NBEV] has a Price to Book Ratio of 2.53.
Shifting the focus to workforce efficiency, New Age Beverages Corporation [NBEV] earns $58,673 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 6.03 and its Total Asset Turnover is 0.29. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 1.07 and its Current Ratio is 1.74. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.New Age Beverages Corporation [NBEV] has 73.16M shares outstanding, amounting to a total market cap of $296.30M. Its stock price has been found in the range of 1.30 to 9.99. At its current price, it has moved down by -62.51% from its 52-week high, and it has moved up 188.08% from its 52-week low.
This stock’s Relative Strength Index (RSI) is at 29.56. This stock, according to these metrics, is currently Oversold.
Conclusion: Is New Age Beverages Corporation [NBEV] a Reliable Buy?
New Age Beverages Corporation [NBEV] stock is presenting a less attractive investment opportunity when compared to similarly-sized corporations in the same industry. The price performance of these shares has not shown much promise, and the financial results that this company has recently delivered present a highly risky investment.
By Kevin Freeman: I deliver world-class ebooks, articles, papers, newsletters, seminar content and presentations. My expertise is in finance and economics, both fundamental principles and ongoing changes in capital markets. My promise to deliver is backed by various articles and knowledge on hedge funds, market and stock analysis, different investment vehicles, and personal finance among others. I also have a decade of solid experience in financial planning, capital raising, and asset management both in listed securities and private equity (early to mid-stage capital) both for individual and institutional portfolios.
https://dwinnex.com/2019/07/22/new-age-beverages-corporation-nbev-holding-strong-whats-pushing-it-2/
Brent David Willis Net Worth
https://wallmine.com/people/63466/brent-d-willis.amp
The estimated Net Worth of Brent D Willis is at least $8.21 Million dollars as of 15 July 2019. Mr Willis owns over 25,000 units of New Age Beverages stock worth over $6,023,434 and over the last 13 years he sold NBEV stock worth over $1,825,750. In addition, he makes $362,500 as CEO & Director at New Age Beverages.Mr Willis NBEV stock SEC Form 4 insider tradingMr has made over 5 trades of the New Age Beverages stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 25,000 units of NBEV stock worth $100,000 on 15 July 2019. The largest trade he's ever made was selling 300,000 units of New Age Beverages stock on 5 April 2019 worth over $1,611,000. On average, Mr trades about 40,152 units every 35 days since 2006. As of 15 July 2019 he still owns at least 1,632,367 units of New Age Beverages stock. You can see the complete history of Mr Willis stock trades at the bottom of the page.Mr. Brent David Willis biographyBrent David Willis is the CEO & Director at New Age Beverages.What is the salary of Mr Willis?As the CEO & Director of New Age Beverages, the total compensation of Mr Willis at New Age Beverages is $362,500. There are no executives at New Age Beverages getting paid more.How old is Mr Willis?Mr Willis is 57, he's been the CEO & Director of New Age Beverages since . There are 2 older and 2 younger executives at New Age Beverages. The oldest executive at New Age Beverages Corp. is Richard C. Rife, 64, who is the Chief Legal & Admin. Officer and Corp. Sec..What's Mr Willis's mailing address?Brent's mailing address filed with the SEC is 1700 E 68th Ave, Thornton, CO 80229, USA.Insider trading at New Age BeveragesOver the last 2 years, insiders at New Age Beverages have traded over $5,509,481 worth of New Age Beverages stock and bought 1,881,821 units worth $3,112,047 . The most active insider traders include Ed Brennan, Brent D Willis, and Neil Fallon. On average, New Age Beverages executives and independent directors trade stock every 46 days with the average trade being worth of $592,182. The most recent stock trade was executed by Brent D Willis on 15 July 2019, trading 25,000 units of NBEV stock currently worth $100,000What does New Age Beverages do?New Age Beverages Corporation develops, markets, sells, and distributes healthy liquid dietary supplements and ready-to-drink (RTD) beverages. The company offers RTD tea, coffee, kombucha, energy drinks, relaxation drinks, coconut waters, functional waters, and rehydration beverages, as well as functional medical beverages. It provides its products under the Búcha Live Kombucha, XingTea, XingEnergy, Marley One Drop, Marley Mellow Mood, Marley Mate, Marley Cold Brew, Coco-Libre, PediaAde, Tahitian Noni Juice, TruAge, and Aspen Pure brands, as well as the Bio-Shield and NHanced brands. The company sells its products across 50 states in the United States; and approximately 60 countries internationally through direct-store-delivery systems, brokers and distributors, warehouses, independent product consultants, and e-commerce sites, as well as through grocery retail, natural food retail, specialty outlets, hypermarkets, club stores, pharmacies, convenience stores, gas stations, and individual independent distributors. New Age Beverages Corporation was founded in 2010 and is based in Denver, Colorado.Complete history of Mr Willis stock trades at Cott (Canada) and New Age Beverages
Insider
Trans.
Total price
Brent D Willis
Chief Executive Officer
Sale $100,000
2019-07-15
Brent D Willis
Chief Executive Officer
Sale $114,750
2019-06-17
Brent D Willis
Chief Executive Officer
Sale $1,611,000
2019-04-05
Brent D Willis
Chief Executive Officer
Buy $99,840
2018-08-24
Brent D Willis
Chief Executive Officer
Buy $100,107
2018-05-18
New Age Beverages executives and stock owners New Age Beverages executives and other stock owners filed with the SEC include:
Brent David Willis
CEO & Director
Gregory A. Gould CPA, CPA
Chief Financial Officer
Chuck Ence
VP of Fin. & Corp. Controller
Randall N. Smith
Pres of Morinda Holdings, Inc.
Richard C. Rife
Chief Legal & Admin. Officer and Corp. Sec.
Gregory A Gould
CFO
Amy L. Kuzdowicz
Reginald Kapteyn
Robert J. Evans
Brent D Willis
Chief Executive Officer
Gregory Fea
Ed Brennan
Julie Anderson
Neil Fallon
Timothy J Haas
CEO LEAVES BEVERAGE MAKER COTT
Cott Corp. (TSX: BCB) shares jumped more than 12 per cent Monday after the company parted ways with Brent Willis, the chief executive officer brought in to help rescue the soda pop maker.Stock in the biggest maker of store-brand soft drinks gained 23 cents to $2.08 on the Toronto Stock Exchange. Cott shares had hit a low of $1.74 last week, down from a 52-week high of $19.70.Cott, which lost $76.8 million (U.S.) in the fourth quarter, said director David Gibbons has been named interim CEO effective immediately.Willis had taken over as chief executive in late May 2006, presiding over a series of production glitches amid rising costs for plastic and other materials, and ebbing demand for fizzy soft drinks.He had previously worked at InBev NV, the world's largest brewer, and succeeded John Sheppard, who also lasted only about two years as Cott's CEO.Willis was spectacularly unsuccessful in arresting the decline," said Peter Holden, an analyst with Veritas Investment Research.”Margins have been steadily falling, volumes have been dropping." Cott has struggled to maintain its private-label beverage dominance in the face of changing tastes and intensifying big-brand competition. Last month the company received notice it was losing some of its shelf space and merchandising support at Wal-Mart in the United States, its biggest customer.To help counter the flattening popularity of carbonated drinks, Cott has shifted its focus to bottled water and energy drinks.Gibbons said that the board has asked him to remain committed to the company's strategy.This "calls for continued focus on our core retailer-branded CSD (carbonated soft drink) business while pursuing new products and channels that reflect the changing consumer landscape," stated Gibbons, previously CEO of retailer-brand over-the-counter drug maker Perrigo Co.Cott chairman Frank Weise lauded Gibbons' knowledge of the private-label business and customer relationships, and added: "The internal challenges that we have experienced in no way negate our strategy, our industry position, or our potential for growth and success."However, the long-term outlook is "very gloomy," said analyst. I don’t think the next management will have any more luck that the previous management, or the management before that," he said."It's more than just the past two years. The company has been in decline for three or four years."According to Cott's latest disclosure, almost a year old, Willis, 48, earned total compensation of $3.6 million (U.S.) for his seven months of service in 2006, and his employment contract guaranteed a termination or resignation payment of two year's salary and bonus, plus vesting of share awards.https://www.thestar.com/business/2008/03/24/ceo_leaves_beverage_maker_cott.html
Big Payday for Fired Cott CEO
BY DAN MITCHELL
UPDATED ON: APRIL 15, 2008 / MONEYWATCH—CBS NEWS
For a chief executive who just finished presiding over a breathtaking corporate downfall, Brent Willis, the recently ousted CEO of Canadian soft-drink maker Cott, is taking home a nice chunk of money.
The company filed documents with the Securities and Exchange Commission revealing that Mr. Willis will go home with nearly $3.5 million. As per his employment agreement, that includes twice his annual base salary and an annual bonus for 2007, a month's pay in lieu of notice of termination, proceeds from stock options, a buyout of his medical benefits, and even a pro-rated bonus for 2008.
Late last month, Cott fired Mr. Willis and appointed a board member, David Gibbons, as interim CEO. The company cited "the business climate and the stock price" as reasons for Mr. Willis' ouster, according to the Financial Post. In February, the stock fell nearly 60 percent in two days after the company said that Wal-Mart, Cott's biggest customer, would be reducing the shelf space it gave to the company's carbonated soft drinks.
Cott is reportedly negotiating with Wal-Mart over how much shelf space it will lose. Last week, Invesco, a major mutual fund operator, announced that it had reduced its stake in the company from more than 11 percent to less than 5 percent.First published on April 15, 2008 / 8:13 PM © 2008 CBS Interactive Inc.. All Rights Reserved.
AB InBev Brews Up Elderflower Ale and Canned Cocktails for Growth https://www.bloomberg.com/news/articles/2019-07-22/ab-inbev-brews-up-cannabis-drinks-and-canned-cocktails-for-growth
Curb Your Enthusiasm - LOL = Verbal texting - Season 8 Ep. 3
Non – Alcoholic Beverage 3650 Market Growth Probability, Key Vendors and Future Scenario Up To 2024
July 10, 2019 No Comments Non - Alcoholic Beverage 3650 Market Research Report
The Non – Alcoholic Beverage 3650 Market report provides an unbiased and detailed analysis of the on-going trends, opportunities/ high growth areas, market drivers, which would help stakeholders to device and align Non – Alcoholic Beverage 3650 market strategies according to the current and future market The Non – Alcoholic Beverage 3650 Market report covers the Global market and regional market analysis. The Non – Alcoholic Beverage 3650 industry report examines, keep records and presents the worldwide market size of the important players in each region around the globe. Also, the report offers information of the leading market players in the Non – Alcoholic Beverage 3650 market.
Access Global Non – Alcoholic Beverage 3650 Market Research Report Details at: at https://www.pioneerreports.com/report/433285
About Non – Alcoholic Beverage 3650 Industry
–
The overviews, SWOT analysis and strategies of each vendor in the Non – Alcoholic Beverage 3650 market provide understanding about the market forces and how those can be exploited to create future opportunities.
Key Players in this Non – Alcoholic Beverage 3650 market are:–
Calcol Inc.
Danone
Nestle S.A.
PepsiCo Inc.
Monster Beverage Company
San Benedetto
Taisun Enterprise Co. Ltd.
Coca Cola Company
Dydo Drinco Inc.
Attitude Drinks
Berry Blendz
Hangzhou Wahaha Group
Request for Sample Copy of this Non – Alcoholic Beverage 3650 Market Report at https://www.pioneerreports.com/request-sample/433285
Production Analysis: SWOT analysis of major key players of Non – Alcoholic Beverage 3650 industry based on a Strengths, Weaknesses, company’s internal & external environments. …, Opportunities and Threats. . It also includes Production, Revenue, and average product price and market shares of key players. Those data are further drilled down with Manufacturing Base Distribution, Production Area and Product Type. Major points like Competitive Situation and Trends, Concentration Rate Mergers & Acquisitions, Expansion which are vital information to grow/establish a business is also provided.
Application of Non – Alcoholic Beverage 3650 Market are:
Speciality Stores
Online Store
Convinience Stores
Product Segment Analysis of the Non – Alcoholic Beverage 3650 Market is:
Carbonated drinks
Non-Carbonated
Look into Table of Content of Non – Alcoholic Beverage 3650 Market Report at https://www.pioneerreports.com/TOC/433285
Geographically this report covers all the major manufacturers from India, China, USA, UK, and Japan. The present, past and forecast overview of Non – Alcoholic Beverage 3650 market is represented in this report.
The report offers the market growth rate, size, and forecasts at the global level in addition as for the geographic areas: Latin America, Europe, Asia Pacific, North America, and Middle East & Africa. Also it analyses, roadways and provides the global market size of the main players in each region. Moreover, the report provides knowledge of the leading market players within the Non – Alcoholic Beverage 3650 market. The industry changing factors for the market segments are explored in this report. This analysis report covers the growth factors of the worldwide market based on end-users.
Inquire for further detailed information of Non – Alcoholic Beverage 3650 Market Report at: https://www.pioneerreports.com/pre-order/433285
Manufacturing Analysis Non – Alcoholic Beverage 3650 Market
Manufacturing process for the Non – Alcoholic Beverage 3650 is studied in this section. It includes through analysis of Key Raw Materials, Key Suppliers of Raw Materials, Price Trend of Key Raw Materials, cost of Raw Materials & Labor Cost, Manufacturing Process Analysis of Non – Alcoholic Beverage 3650 market
Marketing Strategy Analysis, Distributors/Traders Analysis of Non – Alcoholic Beverage 3650 Market
Various marketing channels like direct and indirect marketing are portrayed in Non – Alcoholic Beverage 3650 market report. Important marketing strategical data , Marketing Channel Development Trend, , Pricing Strategy, Market Positioning, Target Client Brand Strategy and Distributors/Traders List
In this study, the years considered to estimate the market size of Non – Alcoholic Beverage 3650 Market are as follows:-
History Year: 2013-2017
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2024
No Of Pages in Non – Alcoholic Beverage 3650 Market Report: 112
Single User Licence Price: USD
Purchase Report at https://www.pioneerreports.com/checkout/433285
Non – Alcoholic Beverage 3650 market reports deliver insight and expert analysis into key consumer trends and behaviour in marketplace, in addition to an overview of the market data and key brands. Non – Alcoholic Beverage 3650 market reports provides all data with easily digestible information to guide every businessman’s future innovation and move business forward.
Global Nonalcoholic Drinks Market 2019 Business Scenario – A.G. Barr, Dr. Pepper Snapple Group, Dydo Drinco, Attitude Drinks, Livewire Energy, Calcol etc. – World Analytics. https://worldanalytics24.com/global-nonalcoholic-drinks-market-2019-business-scenario-a-g-barr-dr-pepper-snapple-group-dydo-drinco-attitude-drinks-livewire-energy-calcol-etc/380293/
$CLCL U.S. Marijuana Sales Should More Than Double to $22 Billion by 2022 -- The Motley Fool https://www.fool.com/investing/2019/07/07/us-marijuana-sales-should-more-than-double-to-22-b.aspx
Please visit our 3 websites on Facebook, our two Twitter accounts, our Company description on otcmarkets.com, and you are most welcome to buy our products either wholesale or retail. A simple google search of images will show you photos of our American made products for sale. Our CEO’s bio (verified) is printed in many editions of Marquis Who’s Who in America, Who’s Who in Asia, and Who’s Who in the World, which can be found at any library and online.Thanks! CALCOL INC. (CLCL-OTC)
Kulong Cool Dragon Energy Drink is on the market in several different places in several different countries. Thanks!
Please visit our 3 websites on Facebook, our two Twitter accounts, our Company description on otcmarkets.com, and you are most welcome to buy our products either wholesale or retail. A simple google search of images will show you photos of our American made products for sale. Our CEO’s bio (verified) is printed in many editions of Marquis Who’s Who in America, Who’s Who in Asia, and Who’s Who in the World, which can be found at any library and online.Thanks! CALCOL INC. (CLCL-OTC)
Please visit our three websites on Facebook, our two Twitter accounts, our Company description on otcmarkets.com, and you are most welcome to buy our products either wholesale or retail. Thanks! CALCOL INC. (CLCL-OTC)
ONE MORE STEP FOR MEDICINAL MARIJUANA NY TIMES NORMAN C KAPLAN
SEPT. 6, 1983
As printed in the New York Times and cited in the US Congressional Record by Congressman Louis Stokes (D21-Ohio) in 1983:
NY TIMES Archives | 1983
ONE MORE STEP FOR MEDICINAL MARIJUANA
SEPT. 6, 1983
About the Archive
This is a digitized version of an article from The Times’s print archive, before the start of online publication in 1996. To preserve these articles as they originally appeared, The Times does not alter, edit or update them.
To the Editor:
As a cancer researcher who has worked with the marijuana derivative Delta-9-Tetrahydrocannabinol for the past five years, both in its anti- cancer properties and in its anti-nausea properties for patients receiving cancer chemotherapy, I applaud your Aug. 27 editorial ''Marijuana and Medicine.''
A recent computer search of the medical literature revealed that over 50 articles on the therapeutic uses of the derivative and its analogues were published in the last three years. I have often commented on the tragic circumstances that in the past allowed this drug with tremendous medical potential to be readily available illegally to the individual on the street while it was difficult, nigh impossible, for the person suffering the ravages of cancer and chemotherapy to obtain.
Nevertheless, both the National Cancer Institute and the National Institute on Drug Abuse have made every effort in recent years to make Delta-9-Tetrahydrocannabinol capsules (Schedule I) available free to those suffering with cancer, and to make it available to researchers like myself working with scientific protocols acceptable to research committees within the state and Federal establishment. What is needed, as you state, is for the Food and Drug Administration and the Drug Enforcement Administration, under the urging of Congress, the scientific and medical community and the public, to move therapeutic Delta-9-Tetrahydrocannabinol from Schedule I (Investigational Experimental Substance) to Schedule II (Controlled Narcotic), which would enable any licensed oncologist, surgeon, opthalmologist, psychiatrist or other physician to prescribe it without excessive regulation or fear of legal liability for use of an ''experimental'' pharmaceutical. For responsible medical researchers, the substance has been and remains available; the problem is to ease the bureaucratic tangle that makes it difficult for physicians to order it and supply it to their patients. NORMAN CHARLES KAPLAN Shaker Heights, Ohio, Aug. 27, 1983
The writer is president of Calcol Inc., a medical and scientific research and consulting firm.
????? ????
??.???
NORMAN C KAPLAN
(CALCOL INC.(CLCL-OTC)
MALIBU-COLA BEVERAGE CO. LTD.
BEIJING KULONG ENERGY TRADING CO. LTD.
KULONG ENERGY BEVERAGE COMPANY INC.
FACEBOOK: NORMAN KAPLAN, CALCOL INC.,KULONG ENERGY BEVERAGE
COMPANY INC.
PO BOX 22228
BEACHWOOD OHIO 44122